Riskpilot← Back to searchSign inGet full accessAlfasigma Sweden AB
ABActiveOrg 5593114548StockholmWholesale of pharmaceutical and medical goods · NACE 4646Est. 20217 employees
Revenue 2024
SEK 25M
-29% vs 2023
EBITDA margin
8.8%
-13% vs 2023
Equity ratio
22.4%
Financial strength
Net profit 2024
SEK 1,2M
-40% vs 2023
| Revenue | SEK 25M | -29% |
| EBITDA | SEK 2,2M | -13% |
| Net profit | SEK 1,2M | -40% |
| Total assets | SEK 27M | +158% |
| Equity | SEK 6M | +26% |
| Employees | 7 | — |
Legal name
Alfasigma Sweden AB
Org number
5593114548
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12 april 2021
Share capital
SEK 25 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Simonelli, Tatiana
Company purpose
Bolagets verksamhet ska vara att utföra alla aktiviteter direkt eller indirekt relaterade till inköp, tillverkning, behandling eller ompaketering, representation, beviljande och uttagande av licenser, försäljning, import och export av farmaceutiska, biologiska, kemiska, medicinska och relaterade produkter och tjänster samt sjukhus- och laboratorieutrustning inklusive utrustning, maskiner och delar, samt bedriva därmed förenlig verksamhet.
Address
Stockholm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 5 329 | 31 996 | 35 085 | 25 033 |
| Staff expenses | — | — | — | — |
| EBITDA | 489 | 3 065 | 2 508 | 2 193 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 489 | 3 065 | 2 508 | 2 193 |
| Net financials | −4 | −111 | 112 | −615 |
| Profit before tax | 484 | 2 954 | 2 620 | 1 578 |
| Tax | −103 | −621 | −564 | −345 |
| Net profit | 381 | 2 333 | 2 056 | 1 233 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 12 564 | 30 400 | 10 454 | 26 961 |
| Equity | 406 | 2 739 | 4 795 | 6 028 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 12 157 | 27 661 | 5 659 | 20 932 |
| Total debt | 12 157 | 27 661 | 5 659 | 20 932 |
EBITDA margin
8.8%
This company
15.8%
Market median
-44% vs market
20212024
Equity ratio
22.4%
This company
38.2%
Market median
-41% vs market
20212024
Return on equity
20.5%
This company
18.4%
Market median
+11% vs market
20212024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20212024
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20212024
Debt / equity
3.47×
This company
0.62×
Market median
-460% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MO Chief Auditor | Chief Auditor | 2024 |
TS External Signatory | External Signatory | 2024 |
CM Authorized Recipient of Service | Authorized Recipient of Service | 2024 |
| Former (2) | ||
MA Authorized Recipient of Service | Authorized Recipient of Service | 2024 – 2024 |
SP External Signatory | External Signatory | 2024 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2024 | |
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (7) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Chairman | 2024 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2022 – 2023 | |
| Board of Directors | 2023 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alfasigma Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Andreas Pauli | Authorized Recipient of Service | 0 companies |
| Stefano Pasi | External Signatory | 0 companies |
| Maria Oussi | Chief Auditor | 0 companies |
| Tatiana Simonelli | External Signatory | 0 companies |
| Carl Magnus Svernlöv | Authorized Recipient of Service | 0 companies |
| Maria Chiara Cucchi | Chairman | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Marcel de Jong | Board of Directors | 0 companies |
| Michele Manto | Board of Directors | 0 companies |
| Samara Orsatti | Chairman | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Bart Filius | Chairman | 0 companies |
| Alberto Avaltroni | Board of Directors | 0 companies |
| Line Henriksen De Linde | Board of Directors | 0 companies |
| Guy Paul J Peeters | Board of Directors | 0 companies |